<DOC>
	<DOCNO>NCT01796587</DOCNO>
	<brief_summary>Primary objective : To evaluate compliance LoFric Origo general intermittent catheterization ( IC ) population use LoFric Origo , mean subjective assessment scale Secondary objective : - To evaluate subject 's perception associate use LoFric Origo , mean subjective assessment scale - To evaluate subject 's discomfort associate use LoFric Origo , mean subjective assessment scale - To observe collect data bladder regimen/IC frequency assessment descriptive data demography , catheter therapy , history patient report outcome . Study Design : Non-interventional study , multicentre , prospective study . Target Subject Population : General intermittent catheterization , LoFric Origo male user . Medical Device : LoFric Origo Study Variable ( ) : - Primary variable : Use No use LoFric Origo 8 week . - Secondary variable ( ) : patient report questionnaire regard perception , discomfort , diagnose , health status , catheter history patient report outcome .</brief_summary>
	<brief_title>Non-Interventional Study Among Users Of LoFric Origo</brief_title>
	<detailed_description />
	<criteria>1 . Provision informed consent . 2 . Males , age 18 year 3 . Practice intermittent selfcatheterization , least one time daily 4 . Subjects use LoFric Origo 5 . Able read fill patient report questionnaire judge investigator 6 . The prescription of/decision use medical device separate decision include subject study . Exclusion Criteria 1 . Simultaneous participation interfere clinical study 2 . Ongoing , symptomatic urinary tract infection ( UTI ) enrolment judge investigator 3 . Involvement plan and/or conduct study ( applies Wellspect HealthCare staff staff study site ) 4 . Previous enrolment present study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>